The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Revolution Medicines
RVMD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$46.44
0.88
1.93%
At Close: -
$46.44
0
0.00%
After Hours: Jul 26, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Revolution Medicines (RVMD) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Revolution Medicines (NASDAQ:RVMD) Stock
Revolution Medicines Stock (NASDAQ: RVMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 18, 2024
Barclays Maintains Overweight on Revolution M...
Benzinga Newsdesk
Tuesday, July 16, 2024
Oppenheimer Maintains Outperform on Revolutio...
Benzinga Newsdesk
B of A Securities Maintains Buy on Revolution...
Benzinga Newsdesk
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
Avi Kapoor
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Revoluti...
Benzinga Newsdesk
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
Friday, July 12, 2024
Barclays Initiates Coverage On Revolution Med...
Benzinga Newsdesk
Thursday, July 11, 2024
Revolution Medicines Announces Publication In...
Benzinga Newsdesk
Tuesday, July 09, 2024
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Revolution shares are trading higher after th...
Benzinga Newsdesk
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Monday, July 08, 2024
Revolution Medicines To Provide Update On RMC...
Benzinga Newsdesk
Jefferies Initiates Coverage On Revolution Me...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on Revolut...
Benzinga Newsdesk
Thursday, May 09, 2024
Wedbush Maintains Outperform on Revolution Me...
Benzinga Newsdesk
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
Wednesday, May 08, 2024
Revolution Medicines Q1 2024 GAAP EPS $(0.70)...
Benzinga Newsdesk
Revolution Medicines Reiterates Projected Ful...
Benzinga Newsdesk
Friday, April 12, 2024
Top 3 Health Care Stocks That May Collapse In Q2
Avi Kapoor
Oppenheimer Maintains Outperform on Revolutio...
Benzinga Newsdesk
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
Wednesday, April 10, 2024
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Raymond James Upgrades Revolution Medicines t...
Benzinga Newsdesk
What's Going On With Revolution Medicines Stock?
Erica Kollmann
Revolution Medicines shares are trading highe...
Benzinga Newsdesk
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Monday, April 08, 2024
Revolution Medicines Announces Publications O...
Benzinga Newsdesk
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
Monday, March 11, 2024
Piper Sandler Initiates Coverage On Revolutio...
Benzinga Newsdesk
Friday, March 08, 2024
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Revoluti...
Benzinga Newsdesk
Tuesday, February 27, 2024
Wedbush Maintains Outperform on Revolution Me...
Benzinga Newsdesk
Monday, February 26, 2024
Revolution Medicines Q4 Sales $700.00K Miss $...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2024
Benzinga Insights
Friday, February 23, 2024
Revolution Medicines's Earnings: A Preview
Benzinga Insights
Tuesday, January 16, 2024
Raymond James Maintains Outperform on Revolut...
Benzinga Newsdesk
Friday, January 05, 2024
B of A Securities Upgrades Revolution Medicin...
Benzinga Newsdesk
Wednesday, December 20, 2023
UBS Initiates Coverage On Revolution Medicine...
Benzinga Newsdesk
Thursday, November 16, 2023
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
Vandana Singh
Raymond James Initiates Coverage On Revolutio...
Benzinga Newsdesk
Monday, November 13, 2023
HC Wainwright & Co. Maintains Buy on Revoluti...
Benzinga Newsdesk
Wednesday, November 08, 2023
Revolution Medicines And EQRx Stockholders Ap...
Benzinga Newsdesk
Tuesday, November 07, 2023
JP Morgan Maintains Overweight on Revolution ...
Benzinga Newsdesk
What 6 Analyst Ratings Have To Say About Revolution Medicines
Benzinga Insights
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
Monday, November 06, 2023
Revolution Medicines Is Updating Its Projecte...
Benzinga Newsdesk
Revolution Medicines Q3 EPS $(0.99) Beats $(1...
Benzinga Newsdesk
Earnings Scheduled For November 6, 2023
Benzinga Insights
Friday, November 03, 2023
Preview: Revolution Medicines's Earnings
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch